Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
111
-
Total 13F shares, excl. options
-
33,526,261
-
Shares change
-
+2,146,533
-
Total reported value, excl. options
-
$614,523,105
-
Value change
-
+$64,351,306
-
Put/Call ratio
-
35%
-
Number of buys
-
54
-
Number of sells
-
-53
-
Price
-
$18.33
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q2 2017
152 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q2 2017.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33,526,261 shares
of 80,437,135 outstanding shares and own 41.68% of the company stock.
Largest 10 shareholders include Consonance Capital Management LP (3,946,009 shares), RTW INVESTMENTS, LP (3,304,214 shares), BlackRock Inc. (3,135,944 shares), D. E. Shaw & Co., Inc. (2,721,675 shares), VANGUARD GROUP INC (2,366,564 shares), GREAT POINT PARTNERS LLC (1,900,000 shares), Boxer Capital, LLC (1,700,000 shares), STATE STREET CORP (1,679,615 shares), FRONTIER CAPITAL MANAGEMENT CO LLC (1,311,758 shares), and WELLINGTON MANAGEMENT GROUP LLP (1,077,202 shares).
This table shows the top 111 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.